Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Skipping Meat on Occasion May Protect Against Type 2 Diabetes

25.06.2019

People who eat less live longer and healthier lives – many studies point out the positive effect of (intermittent) fasting. However, besides calorie reduction, the quantitative relationship of the individual food components also plays an important role. Scientists at DIfE, a partner of the German Center for Diabetes Research, have now demonstrated in the animal model that the sole restriction of the amino acid methionine* prevents the onset of type 2 diabetes. Their results were published in the FASEB Journal.

In earlier studies, the research team of the Department of Experimental Diabetology at the German Institute of Human Nutrition (DIfE) had already discovered that mice fed low-protein chow had improved blood glucose levels and higher energy expenditure than animals fed standard chow.


Thomas Laeger with first author Teresa Castaño-Martinez (center) and a technical assistant in the laboratory of the Department of Experimental Diabetology.

Photo: David Ausserhofer/DIfE

The results of the current study show that the sole reduction of a single amino acid in the chow has a positive effect on health. A diet with low amounts of methionine improved the glucose metabolism of the mice and their sensitivity to the hormone insulin.

"Interestingly, we observed the beneficial effects of a methionine restricted diet without reducing protein levels and regardless of food intake and body fat," said Dr. Thomas Laeger, head of the project.

Transferability to humans: fibroblast growth factor 21 and possible advantages of a vegan and vegetarian diet

The study data suggest that fibroblast growth factor 21 (FGF21) mediates the protective effect of a methionine restricted diet: if less of the amino acid is consumed, the liver releases more FGF21. Vegetarian or vegan diets usually contain low amounts of methionine compared to foods containing meat and fish.

"Together with colleagues from the Department of Molecular Toxicology and the German Federal Institute for Risk Assessment, we demonstrated that people who eat vegetarian or vegan foods have elevated levels of FGF21 in the blood compared to people who eat an omnivore diet," said first author Teresa Castaño-Martinez. After only four days of a vegetarian diet, the FGF21 levels also increased in the blood of the people eating an omnivore diet.

"If the results from the animal model are transferable to humans, this would be an important step in the treatment of diabetes. Instead of counting calories and generally abstaining from tasty protein-rich foods, only the methionine content in the food would have to be reduced. It may already be sufficient for those affected to eat vegetarian for a week from time to time and thus increase their FGF21 levels. This could greatly facilitate the acceptance of a change in diet," said Laeger.

However, it should be noted that certain groups, including children and pregnant and breastfeeding women, have an increased need for methionine.

Further research needed to gain deeper insights into the developmental mechanisms of type 2 diabetes

The scientists agree that the study should be followed up with further research. It would now be important to find out to what extent the reduced methionine uptake actually contributes to the increase in FGF21 levels. In the future, the research team intends to conduct further investigations with vegans in order to uncover additional evidence for the possible involvement of the amino acid methionine in the development of type 2 diabetes.

*Methionine is a sulfur-containing, essential amino acid which the body cannot produce itself and which therefore must be ingested with food. Like all amino acids, it serves as a building block for proteins. Among other things, methionine contributes to the formation of neurotransmitters and hormones and is thus involved in many important body functions. Although certain nuts, oil seeds and vegetables also contain significant amounts of the essential amino acid, a plant-based diet is usually low in methionine compared to a diet with meat and fish.

References

Original Publication:

Castaño-Martinez T, Schumacher F, Schumacher S, Kochlik B, Weber D, Grune T, Biemann R, McCann A, Abraham K, Weikert C, Kleuser B, Schürmann A and Laeger T. Methionine restriction prevents onset of type 2 diabetes in NZO mice. FASEB Journal 2019 Jun;33(6):7092-7102. DOI: 10.1096/fj.201900150R (Open Access)
[https://www.fasebj.org/doi/10.1096/fj.201900150R]

Similar Articles

Laeger T, Castaño-Martinez T, Werno MW, Japtok L, Baumeier C, Jonas W, Kleuser B, and Schürmann A. Dietary carbohydrates impair the protective effect of protein restriction against diabetes in NZO mice used as a model of type 2 diabetes. Diabetologia 2018; 61(6):1459-1469. (Open Access)
[https://link.springer.com/article/10.1007%2Fs00125-018-4595-1]

Background Information

German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE)

The DIfE is a member of the Leibniz Association. It investigates the causes of nutrition-associated diseases in order to develop new strategies for prevention, treatment and nutritional recommendations. Its research interests include the causes and consequences of the metabolic syndrome, a combination of obesity, hypertension (high blood pressure), insulin resistance and lipid metabolism disorder, the role of nutrition for healthy aging and the biological bases of food choices and dietary behavior. DIfE is also a partner of the German Center for Diabetes Research (DZD), which has been funded by the German Federal Ministry of Education and Research (BMBF) since 2009.

German Center for Diabetes Research (DZD)

The German Center for Diabetes Research (DZD) is one of six German Centers of Health Research. It brings together experts in the field of diabetes research and combines basic research, epidemiology and clinical applications. By adopting an innovative, integrative approach to research, the DZD aims to make a substantial contribution to the successful, personalized prevention, diagnosis and treatment of diabetes mellitus. The members of the association are Helmholtz Zentrum München – German Research Center for Environmental Health, the German Diabetes Center Düsseldorf (DDZ), the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), the Institute of Diabetes Research and Metabolic Diseases of Helmholtz Zentrum München at the University of Tübingen, and the Paul Langerhans Institute Dresden of Helmholtz Zentrum München at the University Medical Center Carl Gustav Carus of TU Dresden, associated partners at the universities in Heidelberg, Cologne, Leipzig, Lübeck and Munich, and other project partners.

Media Contacts

Dr. Thomas Laeger
Project Head / Department of Experimental Diabetology
German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE)
phone: +49 (0)33200 88- 2540
e-mail: Thomas.Laeger@dife.de

Sonja Schäche
Head of Press and Public Relations
German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE)
phone: +49 (0)33200 88-2278
e-mail: sonja.schaeche@dife.de / presse@dife.de

Wissenschaftliche Ansprechpartner:

Dr. Thomas Laeger
Project Head / Department of Experimental Diabetology
German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE)
phone: +49 (0)33200 88- 2540
e-mail: Thomas.Laeger@dife.de

Originalpublikation:

Castaño-Martinez T, Schumacher F, Schumacher S, Kochlik B, Weber D, Grune T, Biemann R, McCann A, Abraham K, Weikert C, Kleuser B, Schürmann A and Laeger T. Methionine restriction prevents onset of type 2 diabetes in NZO mice. FASEB Journal 2019 Jun;33(6):7092-7102. DOI: 10.1096/fj.201900150R (Open Access)
[https://www.fasebj.org/doi/10.1096/fj.201900150R]

Sonja Schäche | idw - Informationsdienst Wissenschaft

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Small Protein, Big Impact

In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria.

Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding...

Im Focus: K-State study reveals asymmetry in spin directions of galaxies

Research also suggests the early universe could have been spinning

An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...

Im Focus: New measurement exacerbates old problem

Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.

Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Why developing nerve cells can take a wrong turn

04.06.2020 | Life Sciences

The broken mirror: Can parity violation in molecules finally be measured?

04.06.2020 | Physics and Astronomy

Innocent and highly oxidizing

04.06.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>